TWi Biotech.
安成生物科技股份有限公司
TWi Biotech. is a Taiwan Emerging Stock Board biotechnology company, as of 2026-11-01.
Pipeline
| Asset | Target / mechanism | Stage | Indication | Region | Source date | Source |
|---|---|---|---|---|---|---|
| AC-1101 | — | Phase 1; completed | Granuloma Annulare | United States | 2024-10-15 | Trial registry |
| AC-203 | — | — | — | — | 2026-10-18 | Company disclosure |
| NORA520 | — | Phase 2; completed | Depression, Postpartum; Postpartum Depression; Post-partum Depression; Postnatal Depression; Post-Natal Depression | United States | 2026-07-31 | Trial registry |
Key events
No verified events in the past twelve months.
Related Drugnews articles
No related articles in this language.